Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · IEX Real-Time Price · USD
0.801
-0.025 (-2.98%)
At close: Apr 24, 2024, 4:00 PM
0.790
-0.011 (-1.42%)
After-hours: Apr 24, 2024, 7:37 PM EDT
Kezar Life Sciences Stock Forecast
KZR's stock price has decreased by -67.42% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Kezar Life Sciences stock have an average target of 11, with a low estimate of 2.00 and a high estimate of 20. The average target predicts an increase of 1,272.60% from the current stock price of 0.80.
Analyst Consensus: Buy
* Price targets were last updated on Mar 15, 2024.
Analyst Ratings
The average analyst rating for KZR stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +2,395.63% | Mar 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +2,395.63% | Dec 4, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +2,395.63% | Nov 27, 2023 |
| Wells Fargo | Wells Fargo | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +149.56% | Nov 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +2,395.63% | Oct 12, 2023 |
Financial Forecast
Revenue This Year
2.36M
from 7.00M
Decreased by -66.33%
Revenue Next Year
3.37M
from 2.36M
Increased by 42.85%
EPS This Year
-1.37
from -1.40
EPS Next Year
-1.27
from -1.37
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 14.7M | 21.0M | n/a | 9.7M | 140.4M |
| Avg | 2.4M | 3.4M | n/a | 2.3M | 66.2M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 110.0% | 791.0% | - | - | 5,897.9% |
| Avg | -66.3% | 42.9% | - | - | 2,729.2% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.07 | -0.89 | -0.71 | -0.85 | -0.37 |
| Avg | -1.37 | -1.27 | -1.25 | -1.11 | -0.38 |
| Low | -1.79 | -1.52 | -1.63 | -1.26 | -0.39 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.